LiRIS® Clinical Trial Launched in USA & Canada for Interstitial Cystitis
TARIS Biomedical® has initiated a second Phase 2 study investigating LiRIS in women with Interstitial Cystitis. LiRIS is designed to continuously provide lidocaine over an extended period in the bladder. You may be able to participate! The study is currently active at 13 study centers across the United States and one in Canada, and will [...]